About the Author(s)


Gladys Kigozi-Male Email symbol
Centre for Health Systems Research and Development, Faculty of the Humanities, University of the Free State, Bloemfontein, South Africa

Christo Heunis symbol
Centre for Health Systems Research and Development, Faculty of the Humanities, University of the Free State, Bloemfontein, South Africa

Michelle Engelbrecht symbol
Centre for Health Systems Research and Development, Faculty of the Humanities, University of the Free State, Bloemfontein, South Africa

Raymond Tweheyo symbol
Centre for Health Systems Research and Development, Faculty of the Humanities, University of the Free State, Bloemfontein, South Africa

Department of Health Policy Planning and Management, School of Public Health, Makerere University Kampala, Uganda

Citation


Kigozi-Male G, Heunis C, Engelbrecht M, Tweheyo R. Possible depression in new tuberculosis patients in the Free State province, South Africa. S Afr J Infect Dis. 2024;39(1), a653. https://doi.org/10.4102/sajid.v39i1.653

Original Research

Possible depression in new tuberculosis patients in the Free State province, South Africa

Gladys Kigozi-Male, Christo Heunis, Michelle Engelbrecht, Raymond Tweheyo

Received: 08 Apr. 2024; Accepted: 22 May 2024; Published: 30 Aug. 2024

Copyright: © 2024. The Author(s). Licensee: AOSIS.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background: Despite compelling evidence of comorbidity between tuberculosis (TB) and depression, little is known about the prevalence and determinants of depression among TB patients in the Free State province in South Africa.

Objectives: This study assessed the prevalence and factors associated with possible depression among new drug susceptible TB patients attending primary health care facilities.

Method: The study followed a cross-sectional design. Trained fieldworkers conducted face-to-face interviews with conveniently selected patients. Depression was assessed using the Patient Health Questionnaire-9. Data were subjected to descriptive and binomial logistic regression analyses.

Results: Out of 208 patients, 46.2% screened positive for possible depression – 22.6%, 18.8%, and 4.8% presenting with mild, moderate, and severe symptoms, respectively. Possible depression odds were three times higher among females than males (adjusted odds ratio [AOR]: 3.0; 95% confidence interval [CI]: 1.25–7.32) and 2.7 times higher among extrapulmonary TB (EPTB) than pulmonary TB patients (95% CI: 1.03–7.21). Longer TB treatment duration was protective (AOR: 0.8; 95% CI: 0.70–0.95) against depression. Among human immunodeficiency virus-positive patients, those on antiretroviral therapy (ART) had 2.5 times higher odds of depression (95% CI: 1.13–5.46) than those who were not.

Conclusion: The results highlight a significant burden of possible depression among new TB patients, particularly among females, EPTB patients, and ART recipients. Longer TB treatment duration may offer some protection against depression symptoms, suggesting a need for enhanced adherence support.

Contribution: The results suggest that strengthening TB and mental health service integration is critical to improving treatment outcomes, overall well-being of TB patients, and the performance of the Free State TB programme.

Keywords: tuberculosis; depression; comorbidity; prevalence; Free State province; primary health care.

Introduction

In 2022, approximately 10.6 million people worldwide contracted tuberculosis (TB). Despite a 13.5% decline in cases, the TB incidence rate in South Africa was 468 cases per 100 000 population, well short of the targeted 50% reduction by 2025.1 South Africa reported 280 000 new TB cases, remaining among the 30 high TB burden countries contributing 87% of global cases.1 Subpar TB treatment success and high TB mortality rates have remained areas of continued public health concern for more than two decades. With treatment coverage of 77%, treatment success of 79%, and 54 000 deaths registered in 2022,1 South Africa is sorely challenged to attain the national target of ensuring that at least 90% of all people diagnosed with TB are successfully treated.1,2

TB treatment often complicates with comorbid mental health issues, including depression, anxiety, and psychosis.3,4 A 2020 review in low- and middle-income countries (LMICs) found up to 84% depression prevalence among TB patients.4 Another study5 conducted in South Africa’s Eastern Cape province reported that 8 in 10 TB patients screened positive for at least one psychiatric disorder, including depression and anxiety. Much higher rates of depression are seen in TB populations compared to general populations.6,7

Although depression occurs more frequently among TB patients than the general population, it often remains undiagnosed or misdiagnosed8,9,10,11 because of various factors. For instance, limited access to mental healthcare services, especially in LMICs such as South Africa;12 healthcare providers not prioritising mental health issues;10 insufficient mental health service resources;10,11,12 stigma surrounding mental health may deter patients from discussing their issues;13,14 and overlapping symptoms between TB and depression symptoms can complicate diagnosis.15

The interplay between TB and depression is quite complex. Both conditions share parallel risk factors such as poverty, malnutrition, compromised immune functions, and social stigma.15 To determine which condition came first becomes challenging because of these bi-directional risk factors.8,15 The co-occurrence of TB and depression, compounded by social and economic disparities, hinders healthcare access and worsens outcomes.15 Besides, depression increases the risk of latent TB progressing to active disease.16,17 Depression may also occur during TB treatment,5,18 patients may encounter a broad spectrum of mental health distress, which can range from transient negative emotions, which tend to decrease during the course of TB treatment, to chronic depression characterised by suicide ideation, which may persist beyond the TB period.10 In addition, comorbid depression may aggravate TB treatment non-adherence, increasing the risk of unsuccessful outcomes.19 Furthermore, the side effects of the anti-TB medication may also contribute to depression.16,17,19 To improve the TB programme performance, it is imperative to understand the magnitude of depression, identify its risk factors, and devise ways to manage depression in TB patients optimally.

Research conducted in 2018 on the state of mental healthcare service collaboration in the Free State province of South Africa identified limited screening for mental health conditions at primary health care (PHC) facilities, with severe mental health conditions, referred upwards to district and regional hospitals.20 However, little is known about the prevalence and determinants of depression among new TB patients presenting at PHC facilities in the Free State. Therefore, our study sought to examine the prevalence and factors associated with possible depression among patients attending selected PHC facilities in this province.

Research design and methods

Design and setting

The study followed a cross-sectional design. Data were gathered among TB patients across 11 PHC facilities in the Free State province from November 2019 to December of 2019. The Free State, with 10 994 new TB cases and a mortality rate of 10.6% in 2019 – the highest among the nine South African provinces21 – was purposefully selected for the study. Despite prevailing calls for integration, health services at the PHC level in this province are largely verticalised.22,23 The National Mental Health Policy Framework has only recently endorsed including mental health data elements in the District Health Information System.24 Prior to this, mental health statistics were not routinely captured and considered by the TB programme.

Participants

Given the constraint of limited resources, data collection was undertaken over one month, during which 208 patients were conveniently interviewed. Patients were eligible for the study if they were 18 years or older, on susceptible TB treatment, and could express themselves in English or Sesotho. Patients who were too ill to be interviewed and those who were already diagnosed with mental health conditions at the time of the research visit were excluded from the study. Patients undergoing TB re-treatment and those diagnosed with drug-resistant TB were excluded from the study as they tend to present with more severe and chronic TB disease involving complex treatment regimens and frequent hospitalisation.

To ensure that this study had sufficient statistical power (at least 80%), the G–Power calculator for sample size estimation was utilised.25 In the analysis utilising sex as a predictor variable and given the preponderance of depression among females,8 it was assumed that 50% of women and 30% of men would exhibit symptoms of depression, with an odds ratio (OR) of 2.33 between the two groups. Considering a desired margin of error of 0.05, the calculation indicated that a minimum sample size of 190 patients would be necessary for a robust binomial logistic regression analysis. This sample would ensure that the study was adequately powered to provide reliable estimates.

Instrument and data collection

A structured fieldworker-administered questionnaire was used to collect the data. Socio-demographic questions included age, sex, and social support. With three questions, the Oslo Social Support Scale (OSSS-3)26 was used to measure patients’ perceptions of social support: Firstly, ‘How many people are so close to you that you can count on them if you have great personal problems?’ Response options included: 1 = ‘none’, 2 = ‘1 to 2 people’, 3 = ‘3 to 5 people’, and 4 = ‘more than 5 people’. Secondly, ‘How much interest and concern do people show in what you do?’ Response options included: 1 = ‘none’, 2 = ‘little’, 3 = ‘uncertain’, 4 = ‘some’, and 5 = ‘a lot’. Thirdly, ‘How easy is it to get practical help from neighbours?’ Response options included: 1 = ‘very difficult’, 2 = ‘difficult’, 3 = ‘possible’, 4 = ‘easy’, and 5 = ‘very easy’. The OSSS-3 has demonstrated a somewhat acceptable internal consistency of 0.6, primarily attributed to its brevity.26 Despite this, the scale is widely used in diverse research settings because of its conciseness and ease of administration.26

Possible depression was measured using the nine-item Patient Health Questionnaire (PHQ-9).27,28 The scale assessed the frequency of depressed mood during the two weeks before the research visit. Responses were recorded on a 4-point Likert scale: 0 = ‘not at all’, 1 = ‘several days’, 2 = ‘more than half the days’, and 3 = ‘nearly every day’. Adjustments were made to the response set to enhance respondent comprehension such that ‘several days’ was defined as ‘1 to 7 days’, ‘half the days’ was defined as ‘8 to 11 days’, and ‘nearly every day’ was defined as ‘12 to 14 days’. The PHQ-9 has been found to be valid and reliable for use among TB patients in South Africa.29 Clinical information extracted from patient records at the PHC facilities included TB disease classification, treatment duration, alcohol use, tobacco use, human immunodeficiency virus (HIV) status, and antiretroviral treatment (ART) status.

The questionnaire and consent form were available in English and Sesotho. A bilingual translator performed a forward translation of the research instruments from English into Sesotho. Then, another bilingual translator translated the Sesotho versions back into English. Thereafter, both translators compared the back-translated versions to the original versions of the research instruments, engaging in discussions to resolve any emerging discrepancies and reach a consensus.

A team of experienced bilingual fieldworkers, proficient in Sesotho and English, conducted face-to-face interviews in the patients’ preferred language. Participants were recruited with the assistance of healthcare providers. After their consultation session, the attending nurse referred eligible patients to trained fieldworkers waiting in private rooms within the PHC facility. The fieldworkers were trained to look for signs of distress and refer patients to a social worker or psychologist attached to the PHC facility for further assistance. The fieldworkers scored the patients on the PHQ-9 immediately after the interviews. Patients whose PHQ-9 scores suggested possible depression (≥ 5)27,28 were referred to the social workers or psychologists for further evaluation and diagnosis. The questionnaire took approximately 10 minutes to complete.

Data analysis

Data were analysed using the IBM Statistical Package for the Social Sciences (SPSS) statistics (version 27).30 Discrete variables were presented as frequency counts and percentages, and continuous variables were presented as means (standard deviations [s.d.]) and medians (inter-quartile range [IQR]). Chi-square tests of independence were used to assess whether there were significant differences between categorical variables. Sum scores were computed for the OSSS-3, ranging from 3 to 14. Higher scores represented more robust levels of social support.26 Similarly, sum scores were computed for the PHQ-9, with scores above 4 suggesting possible depression.27,28 Regarding the grading of symptoms based on the PHQ-9, total scores falling between 0 and 4 suggested minimal symptoms, scores ranging between 5 and 9 suggested mild symptoms, scores between 10 and 14 suggested moderate symptoms, and scores falling between 15 and 27 suggested severe symptoms.27,28

Binomial logistic regression was performed to ascertain the factors associated with possible depression. The outcome variable was possible depression, defined as a score of ≥ 5 on the PHQ-9. The following key assumptions for the binomial logistic regression were inspected. Firstly, the independence of observations was examined using plots of standardised residuals and predicted values, and a random scatter of points around zero was demonstrated, suggesting independence. Secondly, the linearity of the logit of continuous variables was inspected using the Box Tidwell procedure. Based on this assessment, all continuous variables were linearly related to the logit transformation of the dependent variable. Thirdly, the occurrence of extreme outliers examined through inspection of studentised residuals identified two potential outliers with values greater than 2, while the inspection of the leverage values identified five high-leverage values. Since these unusual points were not because of data entry errors, the cases were maintained in the analysis. Fourthly, multicollinearity was assessed using a simple correlation analysis among continuous variables. The analysis established that the correlation coefficients were all less than 0.7, suggesting an absence of multicollinearity.

A test of the full model against a constant-only model was statistically significant (χ2 = 26.410, p < 0.001, degrees of freedom [df] = 9), indicating that the predictors, as a set, reliably distinguished between possible depression and the absence of symptoms. The model explained 23.5% (Nagelkerke’s R2) of the variance of possible depression. The overall prediction success was 69.9%, with a specificity of 65.6% and a sensitivity of 73.6%. The positive predictive value was 68.9%, and the negative predictive value was 70.7%. Statistical significance was considered at a 95% confidence interval (CI) and p < 0.05.

Ethical considerations

Ethical approval for this study was received from the Health Sciences Research Ethics Committee, University of the Free State (UFS-HSD2019/1574/2611). The Free State Department of Health authorised access to PHC facilities to interview TB patients. Participation in the study was voluntary; prospective respondents were provided with information regarding the purpose of the research and potential risks to enable them to make an informed choice on whether to participate. Respondents signed informed consent forms consenting to the interviews and for their clinical information to be collected from the patient files. The paper-based data were captured in SPSS and secured in encrypted files on a password-protected computer. All data-gathering instruments, including informed consent forms and questionnaires, were kept in locked cabinets. If patients experienced emotional discomfort or distress during the interviews, or their PHQ-9 scores were higher than 4, suggesting possible depression, they were referred to a social worker or psychologist attached to the PHC facility for further assistance. Furthermore, all participants’ information was handled confidentially. The research team was required to sign statements agreeing to protect the security and confidentiality of participants’ information. Patients’ names and other identifying information were collected to verify their clinical information. However, the data were aggregated for dissemination. Efforts were made to ensure infection control during the data-gathering exercise. The patient interviews occurred in privately situated and well-ventilated rooms within the PHC facilities.

Results

Patients’ socio-demographic and clinical characteristics

Table 1 depicts the socio-demographic and clinical characteristics of the 208 patients interviewed in this study. Most patients were male (n = 137, 65.9%). The mean age of the sample was 42.4 (s.d.: 15.2) years and the median age was 38.5 (IQR: 30.3–54.0) years. Most patients were diagnosed with pulmonary TB (PTB) (n = 174, 83.7%). The median TB treatment duration was 2.5 (IQR: 1–4) months. More than one-third of the patients were documented in the patient files as, respectively, alcohol (n = 81, 38.9%) and tobacco users (n = 69, 33.3%). About 6 in every 10 patients were co-infected with HIV (n = 118, 56.7%), with the majority (n = 84; 71.2%) being recorded in patient files as receiving ART. Just under half (n = 96; 46.2%) of the patients in this study screened positive for possible depression with 22.6% (n = 47), 18.8% (n = 39), and 4.8% (n = 10) presenting with mild, moderate, and severe symptoms, respectively. Half (n = 59; 50.0%) of the 118 patients co-infected with HIV screened positive for possible depression, with 26.3% (n = 31), 17.8% (n = 21) and 5.9% (n = 7) presenting with mild, moderate and severe symptoms, respectively. While possible depression was higher among TB-HIV coinfected patients than their HIV-negative counterparts, this difference was not statistically significant (χ2 = 1.623, df = 11; p = 0.203).

TABLE 1: Patients’ socio-demographic and clinical characteristics (N = 208).
Factors associated with possible depression

Binomial logistic regression was performed to determine the effect of sex, age, TB disease classification, treatment duration, social support, tobacco and alcohol use, and HIV status on possible depression. The results in Table 2 depict that sex (OR: 3.2; CI: 1.76–5.83) and treatment duration (OR: 0.8; CI: 0.73–0.97) were independently significantly associated with possible depression. However, because of their theoretical association with the dependent variable, all the independent variables were considered in the adjusted model.31 After controlling for all variables in the model, possible depression was significantly associated with sex, TB disease classification, and treatment duration. Female patients were 3 times more likely to present with possible depression compared to their male counterparts (AOR: 3.0; CI: 1.25–7.32). Patients diagnosed with extra pulmonary TB (EPTB) were 2.7 times more likely to present with possible depression compared to those diagnosed with PTB (CI: 1.03–7.21). Alternatively, longer TB treatment was protective against possible depression (AOR: 0.8; CI: 0.73–0.95). Furthermore, Table 3 shows that after adjusting for confounding variables, the likelihood of possible depression was higher among HIV coinfected females (AOR: 2.8; CI: 1.22–6.56), EPTB patients (AOR: 3.5; CI: 1.11–11.50), and patients who were receiving ART (AOR: 2.5; CI: 1.13–5.46) relative to their respective counterparts, and less likely among those on TB treatment for longer (AOR: 0.8; CI: 0.67–0.97).

TABLE 2: Factors associated with possible depression among all TB patients (N = 208).
TABLE 3: Factors associated with possible depression among TB-HIV coinfected patients (N = 118).

Discussion

This study analysed possible depression prevalence and associated factors among new patients on susceptible TB treatment in the Free State province. Nearly half (46.2%) of the TB patients screened positive for possible depression. TB-HIV coinfected patients showed higher levels of possible depression relative to their non-HIV coinfected counterparts, although not statistically significant. Possible depression prevalence was slightly lower than in an Ethiopian study (54%)8 possibly because of the demographic and clinical differences. Unlike the Ethiopian study, this study included patients at any stage of TB treatment, not just within 1 month.

Different levels of TB and depression comorbidity have been documented across the studies conducted on the African continent over the past decade, ranging from a relatively low prevalence of 9.3% in Zambia32 to a notably high prevalence of 61.0% in Cameroon.33 A systematic review of sub-Saharan African studies spanning from 1992 to 2019 further reported a pooled depression prevalence of 39.4% among TB patients.34 While no comparisons were made with general (non-TB) patients, the prevalence of possible depression in this study was slightly higher than the values reported in other populations such as patients with epilepsy (32.7%)35 and pregnant women with no specific condition (22.8%).36 This study’s finding adds to the expanding body of literature substantiating the intricate interplay between TB and mental health disorders and underscores an urgent need for a paradigm shift in service delivery at the PHC level. More specifically, it is imperative to enhance the integration of mental health services into the TB programme to ensure the timely identification and management of mental health conditions such as depression among TB patients, mitigate the stigma associated with mental illness, and strengthen the overall effectiveness of TB programmes. In line with this imperative, the recently unveiled National Mental Health Policy Framework and Strategic Plan highlights, among other efforts, the need for ongoing mental health training for PHC nurses.24

Consistent with global research,8,37,38,39,40,41 this study revealed that female TB patients had about 3 times higher odds of possible depression than males, regardless of HIV status. Future research could investigate whether this gender disparity persists in TB patients. This would inform whether TB programmes should consider gender-specific interventions, particularly mental health screening services, care, and management targeting female patients and their support systems.

Similar to research in Ethiopia,40 possible depression was more pronounced among EPTB than PTB patients, which could potentially be attributed to the difficulty in diagnosis, intense treatment regimens, and the often poor prognosis associated with EPTB.42,43 EPTB has distinct manifestations with symptoms that may not be as widely recognised as those of PTB.42 Thus, the lack of awareness may contribute to patients experiencing stigma and social isolation, potentially affecting their mental health.

Analysis of the HIV coinfected sub-group showed that patients on ART were nearly 3 times more likely to experience possible depression relative to those not receiving ART. Both TB and HIV involve treatment using complex regimens and side effects44,45 associated with these treatments may lead to psychological distress. Thus, TB programmes could explore practical methods for the timely identification and treatment of patients with common mental health problems such as depression. In resource-limited settings such as South Africa, with an accompanying shortage of professional mental health practitioners at the PHC level, using non-mental health specialists such as community health workers46,47,48 could prove highly beneficial for the targeted screening of patients within TB programmes, especially if supplemented with adequate ongoing training, support, supervision and monitoring.47

Similar to findings in Ethiopia,41 longer TB treatment duration was associated with reduced depressive symptoms. Given that a substantial proportion of the patients in our study had mild to moderate depressive symptoms, their symptoms might have improved, and they were potentially feeling better the longer they were on TB treatment. Alternatively, the patients could possibly have gained a better understanding of TB over time, subsequently developing more effective ways to cope with the psychological challenges posed by the disease.

While socio-economic status can significantly affect mental health outcomes,49,50 this study did not establish an association between socio-economic variables such as age, social support, alcohol and tobacco use, and the likelihood of possible depression. Further research is recommended to explore the relationship between socio-economic status and mental health outcomes among TB patients.

This study has some limitations. Firstly, the results were based on a convenient sample of patients and cannot be generalised to all TB patients in the Free State. Secondly, only those patients who were present on the day of the research visit and were well enough to participate were interviewed. There is a possibility that more severely depressed patients were missed, which might have underrepresented the prevalence of possible depression. Thirdly, as the data collection was based on fieldworker-administered questionnaires, some patients might have been inclined to provide socially desirable responses while speaking to the fieldworkers. Fourthly, while clinical information was derived from patient records at the PHC facilities, likely from clinician’s notes, it was not corroborated by laboratory testing or pharmacy dispensing records, or validated screening tools. Nonetheless, the study’s findings offer valuable insights about TB-depression comorbidity that can guide further research and the development of targeted interventions and policies in the future in the Free State and similar settings.

Conclusion

This study highlights a significant burden of possible depression among new TB patients, respectively, estimated at 46.2% among all new TB patients and 50.0% among TB-HIV coinfected patients attending certain PHC facilities in the Free State. The results suggest the need to strengthen integrated TB and mental health service delivery in the province. Patients at high risk of depression, including females, EPTB patients, and TB-HIV-coinfected patients on ART, should be prioritised for mental health screening and provided with adequate psychosocial support. As TB treatment duration seems to give a degree of protection against depressive symptoms, more treatment support is warranted within the care cascade. These are essential steps towards improving treatment outcomes, TB patients’ overall well-being, and the performance of the TB programme in the Free State and similar settings.

Acknowledgements

The authors would like to thank all the patients who participated in this study.

Competing interests

The authors declare that they have no financial or personal relationship(s) that may have inappropriately influenced them in writing this article.

Authors’ contributions

G.K.-M. conceptualised the study, analysed the data and drafted the article. C.H., M.E. and R.T. participated in the initial study design and contributed to article refinement. All the authors read and approved the submitted version of the article.

Funding information

The National Research Foundation (Grant: 116355) and Department of Science and Innovation Africa Health Research and Innovation Programme in partnership with the South African Medical Research Council funded this study (Grant: 96148).

Data availability

The data of this study are not publicly available as individual privacy would otherwise be compromised and are available from the corresponding author, G.K.-M., upon reasonable request.

Disclaimer

The views and opinions expressed in this article are those of the authors and are the product of professional research. It does not necessarily reflect the official policy or position of any affiliated institution, funder, agency, or that of the publisher. The authors are responsible for this article’s results, findings, and content.

References

  1. World Health Organization (WHO). Global tuberculosis report 2023 [homepage on the Internet]. [cited 2023 Jan 26]. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports
  2. STOP TB Partnership, UNOPS. 90(90)90 tuberculosis report for heads of state and governments. Geneva: STOP TB/UNOPS; 2017.
  3. Duko B, Bedaso A, Ayano G. The prevalence of depression among patients with tuberculosis: A systematic review and meta-analysis. Ann Gen Psychiatry. 2020;19(1):30. https://doi.org/10.1186/s12991-020-00281-8
  4. Janse van Rensburg A, Dube A, Curran R, et al. Co-morbidities between tuberculosis and common mental disorders: A scoping review of epidemiological patterns and person-centred care interventions from low-to-middle income and BRICS countries. Infect Dis Poverty. 2020;9(1):4. https://doi.org/10.1186/s40249-019-0619-4
  5. Thungana Y, Wilkinson R, Zingela Z. Co-morbidity of mental ill-health in tuberculosis patients under treatment in a rural province of South Africa: A cross-sectional survey. BMJ Open. 2022;12(11):e058013. https://doi.org/10.1136/bmjopen-2021-058013
  6. De Araújo GS, Pereira SM, Dos Santos DN, Marinho JM, Rodrigues LC, Barreto ML. Common mental disorders associated with tuberculosis: A matched case-control study. PLoS One. 2014;9(6):e99551. https://doi.org/10.1371/journal.pone.0099551
  7. Koyanagi A, Vancampfort D, Carvalho AF, et al. Depression comorbid with tuberculosis and its impact on health status: Cross-sectional analysis of community-based data from 48 low- and middle-income countries. BMC Med. 2017;15(1):209. https://doi.org/10.1186/s12916-017-0975-5
  8. Ambaw F, Mayston R, Hanlon C, Alem A. Burden and presentation of depression among newly diagnosed individuals with TB in primary care settings in Ethiopia. BMC Psychiatry. 2017;17:57. https://doi.org/10.1186/s12888-017-1231-4
  9. Ambaw F, Mayston R, Hanlon C, Medhin G, Alem A. Untreated depression and tuberculosis treatment outcomes, quality of life and disability, Ethiopia. Bull World Health Organ. 2018;96(4):243–255. https://doi.org/10.2471/BLT.17.192658
  10. Mainga T, Gondwe M, Mactaggart I, et al. Qualitative study of patient experiences of mental distress during TB investigation and treatment in Zambia. BMC Psychol. 2022;19;10(1):179. https://doi.org/10.1186/s40359-022-00881-x
  11. Walker IF, Baral SC, Wei X, et al. Multidrug-resistant tuberculosis treatment programmes insufficiently consider comorbid mental disorders. Int J Tuberc Lung Dis. 2017;21(6):603–609. https://doi.org/10.5588/ijtld.17.0135
  12. Marais DL, Petersen I. Health system governance to support integrated mental health care in South Africa: Challenges and opportunities. Int J Ment Health Syst. 2015;9(1):1–21. https://doi.org/10.1186/s13033-015-0004-z
  13. Bell RA, Franks P, Duberstein PR, et al. Suffering in silence: reasons for not disclosing depression in primary care. Ann Fam Med. 2011;9(5):439–446. https://doi.org/10.1370/afm.1277
  14. Mbuthia GW, Nyamogoba HDN, Chiang SS, McGarvey ST. Burden of stigma among tuberculosis patients in a pastoralist community in Kenya: A mixed methods study. PLOS One. 2020;15(10):e0240457. https://doi.org/10.1371/journal.pone.0240457
  15. Sweetland AC, Kritski A, Oquendo MA, et al. Addressing the tuberculosis–depression syndemic to end the tuberculosis epidemic. Int J Tuberc Lung Dis. 2017; 21(8):852–861. https://doi.org/10.5588/ijtld.16.0584
  16. Pachi A, Bratis D, Moussas G, Tselebis A. Psychiatric morbidity and other factors affecting treatment adherence in pulmonary tuberculosis patients. Tuberc Res Treat. 2013;2013;489865. https://doi.org/10.1155/2013/489865
  17. Doherty AM, Kelly J, McDonald C, O’Dywer AM, Keane J, Cooney J. A review of the interplay between tuberculosis and mental health. Gen Hosp Psychiatry. 2013;35(4):398–406. https://doi.org/10.1016/j.genhosppsych.2013.03.018
  18. Vega P, Sweetland A, Acha J, et al. Psychiatric issues in the management of patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2004;8(6):749–759.
  19. Ruiz-Grosso P, Cachay R, De La Flor A, Schwalb A, Ugarte-Gil C. Association between tuberculosis and depression on negative outcomes of tuberculosis treatment: A systematic review and meta-analysis. PLoS One. 2020;10;15(1):e0227472. https://doi.org/10.1371/journal.pone.0227472
  20. Janse van Rensburg A, Petersen I, Wouters E, et al. State and non-state mental health service collaboration in a South African district: A mixed methods study. Health Policy Plan. 2018;33(4):516–527. https://doi.org/10.1093/heapol/czy017
  21. Ndlovu N, Gray A, Mkhabela B, Myende N, Day C. Health and related indicators 2022. Published in South African Health Review 2022 [homepage on the Internet]. [cited 2024 Jan 19]. Available from: https://sahr.hst.org.za/article/82026-health-and-related-indicators-2022
  22. Heunis C, Wouters E, Kigozi G, Janse van Rensburg-Bonthuyzen E, Jacobs N. TB/HIV-related training, knowledge and attitudes of community health workers in the Free State province, South Africa. Afr J AIDS Res. 2013;12(2):113–119. https://doi.org/10.2989/16085906.2013.855641
  23. Malakoane B, Heunis JC, Chikobvu P, Kigozi NG, Kruger WH. Public health system challenges in the Free State, South Africa: A situation appraisal to inform health system strengthening. BMC Health Serv Res. 2020;20(1):58. https://doi.org/10.1186/s12913-019-4862-y
  24. National Department of Health. National mental health policy framework and strategic plan 2023–2030. Pretoria: NDoH; 2023.
  25. Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G– Power 3.1: Tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149–1160. https://doi.org/10.3758/BRM.41.4.1149
  26. Kocalevent R-D, Berg L, Beutel ME, et al. Social support in the general population: standardisation of the Oslo social support scale (OSSS-3). BMC Psychol. 2018;6(1):31. https://doi.org/10.1186/s40359-018-0249-9
  27. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
  28. Kroenke K, Spitzer RL, Williams JBW, Löwe B. The Patient Health Questionnaire somatic, anxiety, and depressive symptom scales: A systematic review. Gen Hosp Psychiatry. 2010;32(4):345–359. https://doi.org/10.1016/j.genhosppsych.2010.03.006
  29. Kigozi G. Confirmatory factor analysis of the Patient Health Questionnaire-9: A study among tuberculosis patients in the Free State province. South Afr J Infect Dis. 2020;35(1):6. https://doi.org/10.4102/sajid.v35i1.242
  30. IBM Corp. IBM SPSS Statistics for Windows, Version 27.0 [homepage on the Internet]. Armonk, New York, IBM Corp; 2020 [cited n.d.]. Available from: https://www.ibm.com/mysupport
  31. Stoltzfus JC. Logistic regression: A brief primer. Acad Emerg Med. 2011;18(10):1099–1104. https://doi.org/10.1111/j.1553-2712.2011.01185.x
  32. Van den Heuvel L, Chishinga N, Kinyanda E, et al. Frequency and correlates of anxiety and mood disorders among TB- and HIV-infected Zambians. AIDS Care. 2013;25(12):1527–1535. https://doi.org/10.1080/09540121.2013.793263
  33. Kehbila J, Ekabe CJ, Aminde LN, Noubiap JJN, Fon PN, Monekosso GL. Prevalence and correlates of depressive symptoms in adult patients with pulmonary tuberculosis in the Southwest Region of Cameroon. Infect Dis Poverty. 2016;5(1):51. https://doi.org/10.1186/s40249-016-0145-6
  34. Amha H, Mulugeta H, Getnet A, et al. Magnitude of depression and associated factors among patients with tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis. J Affect Disord Rep. 2021;4:100080. https://doi.org/10.1016/j.jadr.2021.100080
  35. Dessie G, Mulugeta H, Leshargie CT, Wagnew F, Burrowes S. Depression among epileptic patients and its association with drug therapy in sub-Saharan Africa: A systematic review and meta-analysis. PLoS One. 2019;14(3):e0202613. https://doi.org/10.1371/journal.pone.0202613
  36. Endomba FT, Ndoadoumgue AL, Mbanga CM, et al. Perinatal depressive disorder prevalence in Africa: A systematic review and Bayesian analysis. Gen Hosp Psychiatry. 2021;69:55–60. https://doi.org/10.1016/j.genhosppsych.2021.01.006
  37. Steel Z, Marnane C, Iranpour C, et al. The global prevalence of common mental disorders: A systematic review and meta-analysis 1980–2013. Int J Epidemiol. 2014;43(2):476–493. https://doi.org/10.1093/ije/dyu038
  38. Abdurahman S, Yadeta TA, Ayana DA, Kure MA, Ahmed J, Mehadi A. Magnitude of depression and associated factors among patients on tuberculosis treatment at public health facilities in Harari regional state, eastern Ethiopia: Multi-center cross-sectional study. Neuropsychiatr Dis Treat. 2022;18:1405–1419. https://doi.org/10.2147/NDT.S370795
  39. Xavier PB, Peixoto B. Emotional distress in Angolan patients with several types of tuberculosis. Afr Health Sci. 2015;15(2):378–384. https://doi.org/10.4314/ahs.v15i2.10
  40. Molla A, Mekuriaw B, Kerebih H. Depression and associated factors among patients with tuberculosis in Ethiopia: A cross-sectional study. Neuropsychiatr Dis Treat. 2019;15:1887–1893. https://doi.org/10.2147/NDT.S208361
  41. Dasa TT, Roba AA, Weldegebreal F, et al. Prevalence and associated factors of depression among tuberculosis patients in Eastern Ethiopia. BMC Psychiatry. 2019;19(1):82. https://doi.org/10.1186/s12888-019-2042-6
  42. Denkinger CM, Schumacher SG, Boehme CC, Dendukuri N, Pai M, Steingart KR. Xpert MTB/RIF assay for the diagnosis of extra-pulmonary tuberculosis: A systematic review and meta-analysis. Eur Respir J. 2014;44(2):435–446. https://doi.org/10.1183/09031936.00007814
  43. Cherian JJ, Lobo I, Sukhlecha A, et al. Treatment outcome of extra-pulmonary tuberculosis under Revised National Tuberculosis Control Programme. Indian J Tuberc. 2017;64(2):104–108. https://doi.org/10.1016/j.ijtb.2016.11.028
  44. Resende NHD, Martins UCDM, Ramalho-de-Oliveira D, et al. The medication experience of TB/HIV coinfected patients: Qualitative study. Int J Environ Res Public Health. 2022;19(22):15153. https://doi.org/10.3390/ijerph192215153
  45. Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: A systematic review of qualitative research. PLoS Med. 2007;4(7):e238. https://doi.org/10.1371/journal.pmed.0040238
  46. Patel V, Weobong B, Weiss HA, et al. The Healthy Activity Program (HAP), a lay counsellor-delivered brief psychological treatment for severe depression, in primary care in India: A randomised controlled trial. Lancet. 2017;389(10065):176–185. https://doi.org/10.1016/S0140-6736(16)31589-6
  47. Grant M, Luvuno Z, Bhana A, et al. The development of a Community Mental Health Education and Detection (CMED) tool in South Africa. SSM – Ment Health. 2021;1:100023. https://doi.org/10.1016/j.ssmmh.2021.100023
  48. Pence BW, Stockton MA, Mphonda SM, et al. How faithfully do HIV clinicians administer the PHQ-9 depression screening tool in high-volume, low-resource clinics? Results from a depression treatment integration project in Malawi. Glob Ment Health. 2019;6:e21. https://doi.org/10.1017/gmh.2019.22
  49. Shen R, Zong K, Liu J, Zhang L. Risk factors for depression in tuberculosis patients: A meta-analysis. Neuropsychiatr Dis Treat. 2022;18:847–866. https://doi.org/10.2147/NDT.S347579
  50. Thomas BE, Shanmugam P, Malaisamy M, et al. Psycho-socio-economic issues challenging multidrug resistant tuberculosis patients: A systematic review. PLoS One. 2016;25;11(1):e0147397. https://doi.org/10.1371/journal.pone.0147397


Crossref Citations

No related citations found.